Seno Medical raising $40M to globalize cancer-detection technology

Seno Medical Instruments Inc. expects to have the regulatory approvals needed to commercialize its cancer diagnostic technology in the U.S. and Europe by spring. It’s now embarking on a $40 million fundraising effort to back a multi-continent launch. “A lot of things we’ve been telling investors and the board are finally coming to fruition,” Seno Medical Instruments CEO Tom Umbel said. The company, which secured premarket approval for the initial version of its Imagio Breast Imaging System…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news